{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-138802","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.712367+00:00","generated_at":"2026-05-19T13:11:28.813519+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Tempest Therapeutics suspends ATM prospectus; Sales Agreement remains in effect","bullets":["Delivered notice to Jefferies to terminate ATM prospectus dated Feb 6, 2025.","No sales of common stock under Sales Agreement until new prospectus filed.","Underlying Open Market Sale Agreement with Jefferies remains in full force.","Company retains ability to resume ATM sales after filing new prospectus."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-138802","json":"https://secwatch.observer/filing/0001193125-25-138802.json","markdown":"https://secwatch.observer/filing/0001193125-25-138802.md","text":"https://secwatch.observer/filing/0001193125-25-138802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312525138802/0001193125-25-138802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312525138802/d779986d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:11:28.813519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}